产品介绍：
产品说明
包装
1, 5 mg in glass bottle
生化/生理作用
Dehydrocholesterol reductase inhibitor. Inhibits 7-dehydrocholesterol reductase, which catalyzes the last step of cholesterol synthesis.
特点和优势
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
基本信息
| 经验(实验)分子式 | C22H25ClN2O2 · H2SO4 |
| 分子量 | 482.98 |
| MDL编号 | MFCD07370131 |
| PubChem化学物质编号 | 24892089 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 颜色 | white |
| mp | >300 ℃ |
| 溶解性 | DMSO: soluble 4 mg/mL water: insoluble |
| 创始人 | Roche |
| 储存温度 | 2-8℃ |
| SMILES string | OS(O)(=O)=O.OC(=O)c1ccc(CCN2CCN(CC2)CC=Cc3ccc(Cl)cc3)cc1 |
| InChI | 1S/C22H25ClN2O2.H2O4S/c23-21-9-5-18(6-10-21)2-1-12-24-14-16-25(17-15-24)13-11-19-3-7-20(8-4-19)22(26)27;1-5(2,3)4/h1-10H,11-17H2,(H,26,27);(H2,1,2,3,4) |
| InChI key | OVMQIVIYKXXEIT-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H315 - H319 - H335 |
| 预防措施声明 | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
| 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
